Australian Tim Stobo knew from the public service advisories that malignant melanoma was a growing problem in his country. When the disease struck him, he wanted to fight back, so he enrolled in a CRI/LICR Cancer Vaccine Collaborative clinical trial of a new vaccine to treat melanoma.